NCT02798419View on ClinicalTrials.gov

Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

May 31, 2016

Study Completion Date

August 31, 2016

Conditions
Common Warts
Interventions
DRUG

DFD05 Cream

DRUG

Active01 Cream

Trial Locations (12)

30060

Investigational Site #9, Marietta

33609

Investigational Site #12, Tampa

55432

Investigational Site #8, Fridley

60005

Investigational Site #3, Arlington Hts

70526

Investigational Site #10, Crowley

71913

Investigation Site #1, Hot Springs

77845

Investigational Site #7, College Station

78759

Investigational Site #5, Austin

80904

Investigational Site #2, Colorado Springs

94538

Investigational Site #4, Fremont

95821

Investigational Site #11, Sacramento

02919

Investigational Site #6, Johnston

Sponsors
All Listed Sponsors
lead

Dr. Reddys Laboratories, SA

INDUSTRY